The National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH) is offering the Martin Delaney Collaboratory grant. This grant supports research focused on achieving an HIV cure in pediatric populations, aiming for sustained viral remission or eradication of HIV. This initiative seeks to accelerate progress through coordinated basic, clinical, and applied research. Projects will expand knowledge on HIV latency and persistence in children, develop innovative cure strategies, and design assays to characterize HIV reservoirs, translating findings to clinical settings. The grant targets perinatally infected children and adolescents up to 24 years old, particularly those who received early treatment.
Opportunity ID: 327674
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-AI-20-036 |
| Funding Opportunity Title: | Martin Delaney Collaboratory for Pediatric HIV Cure Research (UM1 Clinical Trial Not Allowed) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Education Health Income Security and Social Services |
| Category Explanation: | – |
| Expected Number of Awards: | 1 |
| Assistance Listings: | 93.242 — Mental Health Research Grants |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Jun 15, 2020 |
| Last Updated Date: | Jun 15, 2020 |
| Original Closing Date for Applications: | Dec 07, 2020 |
| Current Closing Date for Applications: | Dec 07, 2020 |
| Archive Date: | Jan 12, 2021 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $3,500,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Native American tribal organizations (other than Federally recognized tribal governments) City or township governments Public housing authorities/Indian housing authorities For profit organizations other than small businesses County governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Small businesses Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Public and State controlled institutions of higher education Independent school districts Special district governments Private institutions of higher education Native American tribal governments (Federally recognized) Others (see text field entitled “Additional Information on Eligibility” for clarification) State governments |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | This Funding Opportunity Announcement (FOA) is soliciting applications to support research on HIV cure in pediatric populations. This FOA will support coordinated basic, clinical, and applied research focused on developing strategies to achieve an HIV cure, defined as either sustained viral remission or eradication of HIV infection. The cure of HIV infection in people living with HIV (PLWH) is one of the highest priorities of the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH). The goal of the Martin Delaney Collaboratory program is to accelerate progress towards developing strategies to achieve either eradication of HIV infection from the body or a sustained viral remission, as defined by sustained viral suppression following cessation of antiretroviral therapy. Funded projects under this FOA will be expected to expand the knowledge base on HIV latency and persistence in pediatric populations, design and evaluate innovative cure strategies, develop and evaluate assays and other modalities to accurately characterize HIV reservoirs and translate findings to the clinical settings. This funding opportunity will target perinatally infected children and adolescents up to 24 years of age with a primary focus on early treated children. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-20-036.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-F | Use for due dates on or after May 25, 2020 | PKG00262199 | Nov 06, 2020 | Dec 07, 2020 | View |
Package 1
Mandatory forms
327674 RR_SF424_2_0-2.0.pdf
327674 PHS398_CoverPageSupplement_5_0-5.0.pdf
327674 RR_OtherProjectInfo_1_4-1.4.pdf
327674 PerformanceSite_2_0-2.0.pdf
327674 RR_KeyPersonExpanded_2_0-2.0.pdf
327674 RR_Budget_1_4-1.4.pdf
327674 PHS398_ResearchPlan_4_0-4.0.pdf
327674 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
327674 RR_SubawardBudget30_1_4-1.4.pdf
327674 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
